SCHEMBL5644282

SCHEMBL5644282

COC(=O)c1c2c(c3ccccc3c1O)OC(c1ccccc1)(c1ccccc1)C=C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PADI4 Q9UM07 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 2/20 0.36
IDO1 P14902 1/20 0.35
PTPN1 P18031 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PTGS1 P23219 1/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8978509 0.94 L3MBTL1 (0.40) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL29565483 0.94 L3MBTL1 (0.40) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL8978570 0.92 KDM4E (0.36) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL29913570 0.92 KDM4E (0.36) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL5159693 0.92 KDM4E (0.33) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL29565487 0.92 KDM4E (0.33) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL1408896 0.91 ATM (0.41) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL29565080 0.91 ATM (0.41) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL9110844 0.90 KMT2A (0.39) ALDH1A1KDM4EGAAHTTSMN1; SMN2
SCHEMBL1792470 0.89 MEN1 (0.35) ALDH1A1KDM4EGAAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166357-B2 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation TRANSITIONS OPTICAL, INC. (US) 2007-01-23 US claimed
US-20040185268-A1 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation TRANSITIONS OPTICAL LIMITED (IE) 2004-09-23 US claimed
US-20110122475-A1 PHOTOCHROMIC DICHROIC NAPHTHO-PYRANS AND OPTICAL ARTICLES CONTAINING THEM ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2011-05-26 US disclosed
US-7166357-B2 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation TRANSITIONS OPTICAL, INC. (US) 2007-01-23 US disclosed
US-20040185268-A1 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation TRANSITIONS OPTICAL LIMITED (IE) 2004-09-23 US disclosed
EP-1097155-B1 PHOTOCHROMIC SIX-MEMBERED HETEROCYCLIC-FUSED NAPHTHOPYRANS TRANSITIONS OPTICAL INC (US) 2002-09-18 EP disclosed
US-6022497-A NAPHTHOPYRAN COMPOUNDS WHEN EXPOSED TO ELECTROMAGNETIC RADIATION CONTAINING ULTRAVIOLET RAYS, EXHIBIT A REVERSIBLE CHANGE IN COLOR AND WHEN ULTRAVIOLET RADIATION DISCONTINUED THE PHOTOCHROMIC COMPOUND WILL RETURN TO COLORLESS STATE PPG INDUSTRIES OHIO, INC. (US) 2000-02-08 US disclosed
US-5573712-A PHOTOCHROMIC ARTICLE COMPRISING ORGANIC HOST AND THE PHOTOCHROMIC NAPHTHOPYRAN TRANSITIONS OPTICAL, INC. (US) 1996-11-12 US disclosed
US-5458814-A Ophthalmic lenses TRANSITIONS OPTICAL, INC. (US) 1995-10-17 US disclosed
WO-1995016215-A1 NOVEL SUBSTITUTED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 1995-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110122475-A1 PHOTOCHROMIC DICHROIC NAPHTHO-PYRANS AND OPTICAL ARTICLES CONTAINING THEM NR2E3, NR2C2, NR5A2 ALDH1A1 1244/4885KDM4E 3858/4885GAA 4567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.